Nicolas Aubrey

770 total citations
44 papers, 603 citations indexed

About

Nicolas Aubrey is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Nicolas Aubrey has authored 44 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Genetics. Recurrent topics in Nicolas Aubrey's work include Monoclonal and Polyclonal Antibodies Research (22 papers), Venomous Animal Envenomation and Studies (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Nicolas Aubrey is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (22 papers), Venomous Animal Envenomation and Studies (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Nicolas Aubrey collaborates with scholars based in France, Brazil and Morocco. Nicolas Aubrey's co-authors include Philippe Billiald, Igor Chourpa, Christiane Devaux, Émilie Allard-Vannier, Julien Muzard, Isabelle Dimier‐Poisson, Katel Hervé-Aubert, M. Goyffon, Hervé Rochat and Larissa M. Alvarenga and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Analytical Biochemistry.

In The Last Decade

Nicolas Aubrey

41 papers receiving 593 citations

Peers

Nicolas Aubrey

RNMI

GENET

IMMUN

BIOMA

Nrusingh C. Biswal United States

Antoni Benito Spain

Sai Vikram Vemula United States

Pieter De Pauw Belgium

Mark B. Carter United States

Matthew H. Parker United States

Lynne J. Lawrence Australia

Berea A. R. Williams United States

Andreas Hinz Germany

Brian Cass Canada

Nrusingh C. Biswal United States

Nicolas Aubrey

244 ×0.7

145 ×0.7

RNMI

163 ×0.9

GENET

38 ×0.4

IMMUN

39 ×0.6

BIOMA

Citations per year, relative to Nicolas Aubrey Nicolas Aubrey (= 1×) peers Nrusingh C. Biswal

Countries citing papers authored by Nicolas Aubrey

Since Specialization

Citations

This map shows the geographic impact of Nicolas Aubrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Aubrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Aubrey more than expected).

Fields of papers citing papers by Nicolas Aubrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Aubrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Aubrey. The network helps show where Nicolas Aubrey may publish in the future.

Co-authorship network of co-authors of Nicolas Aubrey

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Aubrey. A scholar is included among the top collaborators of Nicolas Aubrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Aubrey. Nicolas Aubrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jallas, Anne-Catherine, Ioana Molnar, Cyril Colas, et al.. (2025). Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. Journal of Medicinal Chemistry. 68(18). 19122–19142.

Mévélec, Marie-Noëlle, Louis Lantier, Laurie Lajoie, et al.. (2025). Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapy. PubMed. 33(2). 200968–200968. 1 indexed citations

Fonseca, Miguel, et al.. (2025). Increasing the developability of lambda chain antibodies: engineering to confer protein L binding activity and its consequences. International Journal of Biological Macromolecules. 313. 144177–144177.

Lantier, Louis, Nathalie Moiré, Laurie Lajoie, et al.. (2024). Specific Cell Targeting by Toxoplasma gondii Displaying Functional Single-Chain Variable Fragment as a Novel Strategy; A Proof of Principle. Cells. 13(11). 975–975. 3 indexed citations

Allard-Vannier, Émilie, et al.. (2024). Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer. Nanoscale. 17(7). 4058–4072.

Allard-Vannier, Émilie, Aurélie Maisonial‐Besset, Jean‐Michel Chezal, et al.. (2024). Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer. Journal of Controlled Release. 366. 567–584. 7 indexed citations

Allard-Vannier, Émilie, Nicolas Aubrey, Igor Chourpa, et al.. (2022). Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics. 14(12). 2679–2679. 2 indexed citations

Minozzo, João Carlos, et al.. (2022). An effective strategy for the humanization of antibody fragments under an accelerated timeline. International Journal of Biological Macromolecules. 216. 465–474. 3 indexed citations

Viaud‐Massuard, Marie‐Claude, et al.. (2021). Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate. European Journal of Medicinal Chemistry. 229. 114063–114063. 9 indexed citations

10.

Hervé-Aubert, Katel, Stéphanie David, Nolwenn Lautram, et al.. (2020). Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics. 157. 74–84. 16 indexed citations

11.

Lacôte, Sandra, Céline Urien, Charles-Adrien Richard, et al.. (2019). A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting. Frontiers in Immunology. 10. 860–860. 13 indexed citations

12.

Allard-Vannier, Émilie, Nicolas Aubrey, H. Marchais, et al.. (2019). Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency. International Journal of Pharmaceutics. 569. 118572–118572. 24 indexed citations

13.

Hervé-Aubert, Katel, Émilie Allard-Vannier, Nicolas Joubert, et al.. (2018). Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide. Bioconjugate Chemistry. 29(5). 1553–1559. 10 indexed citations

14.

Aubrey, Nicolas & Philippe Billiald. (2018). Antibody Fragments Humanization: Beginning with the End in Mind. Methods in molecular biology. 1904. 231–252. 5 indexed citations

15.

Moura, Juliana de, Magali Noiray, João Carlos Minozzo, et al.. (2016). Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism. Immunology Letters. 176. 90–96. 11 indexed citations

16.

Aubrey, Nicolas, Julien Muzard, Carlos Chávez-Olórtegui, et al.. (2016). Immunodetection of the “brown” spider (Loxosceles intermedia) dermonecrotoxin with an scFv-alkaline phosphatase fusion protein. Immunology Letters. 173. 1–6. 14 indexed citations

17.

Muzard, Julien, et al.. (2009). Grafting of protein L-binding activity onto recombinant antibody fragments. Analytical Biochemistry. 388(2). 331–338. 21 indexed citations

18.

Aubrey, Nicolas, et al.. (2006). Anticorps recombinants : vers une nouvelle génération d'antivenins ?. Journal de la Société de Biologie. 200(4). 345–354. 3 indexed citations

19.

Aubrey, Nicolas, Christiane Devaux, P Sizaret, et al.. (2003). Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin. Cellular and Molecular Life Sciences. 60(3). 617–628. 37 indexed citations

20.

Aubrey, Nicolas, Christiane Devaux, Eric di Luccio, et al.. (2001). A Recombinant scFv/Streptavidin-Binding Peptide Fusion Protein for the Quantitative Determination of the Scorpion Venom Neurotoxin AahI. Biological Chemistry. 382(11). 1621–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact